Great Bay Bio self-developed AI-enabled cell culture media, AlfaMedX (NF3370+DF2025), leverages cutting-edge technologies, including AI, to analyze and predict large volumes of experimental data. This approach optimizes the composition and usage conditions of the media, significantly improving protein expression performance.

Since its launch, AlfaMedX (NF3370+DF2025) has received trial data from several of our customers. Comparative studies with 17 commercial media on cell line cultures for fusion proteins, mAbs, and BsAbs have demonstrated its significant advantages in protein yield and versatility. Trial data from 20 different cell lines showed that, compared to commercial media, GBB’s AlfaMedX (NF3370+DF2025) achieved expression levels at or above 90% of the top-performing commercial media in 9 cell lines, with its expression ranking consistently within the top 3.

Detailed trial data are shown below: